122 related articles for article (PubMed ID: 26760818)
1. Livedoid vasculopathy: fast involution after anticoagulant and hyperbaric oxygen therapy.
Bollmann PW; Shimada AK; Michalany NS; Manhani AR; Giglio AD
Einstein (Sao Paulo); 2011 Jun; 9(2):212-5. PubMed ID: 26760818
[TBL] [Abstract][Full Text] [Related]
2. Intractable livedoid vasculopathy successfully treated with hyperbaric oxygen.
Yang CH; Ho HC; Chan YS; Liou LB; Hong HS; Yang LC
Br J Dermatol; 2003 Sep; 149(3):647-52. PubMed ID: 14511004
[TBL] [Abstract][Full Text] [Related]
3. Livedoid vasculopathy with underlying subcutaneous necrotizing venulitis in an asymptomatic hepatitis B virus carrier: is livedoid vasculopathy a true nonvasculitic disorder?
Ishibashi M; Miyamoto J; Nagasaka T; Chen KR
Am J Dermatopathol; 2009 May; 31(3):293-6. PubMed ID: 19384073
[TBL] [Abstract][Full Text] [Related]
4. Livedoid vasculopathy successfully treated with hyperbaric oxygen.
Banham ND
Diving Hyperb Med; 2013 Mar; 43(1):35-6. PubMed ID: 23508660
[TBL] [Abstract][Full Text] [Related]
5. Livedoid vasculopathy: long-term follow-up results following hyperbaric oxygen therapy.
Juan WH; Chan YS; Lee JC; Yang LC; Hong HS; Yang CH
Br J Dermatol; 2006 Feb; 154(2):251-5. PubMed ID: 16433793
[TBL] [Abstract][Full Text] [Related]
6. Livedoid vasculopathy and recurrent thrombosis in a patient with lupus: seronegative antiphospholipid syndrome?
Sopeña B; Pérez-Rodríguez MT; Rivera A; Ortiz-Rey JA; Lamas J; Freire-Dapena MC
Lupus; 2010 Oct; 19(11):1340-3. PubMed ID: 20659971
[TBL] [Abstract][Full Text] [Related]
7. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
[TBL] [Abstract][Full Text] [Related]
8. Penile Livedoid Vasculopathy: First Reported Case.
Hallak A; Bennett W; Tanbir MA; Donthamsetty SR; Vincent B
Case Rep Vasc Med; 2023; 2023():6920383. PubMed ID: 37440957
[TBL] [Abstract][Full Text] [Related]
9. Livedoid Vasculopathy with Hyperhomocysteinemia Responding to Hyperbaric Oxygen Therapy.
Ray R; Sharma A; Vasudevan B; Sridhar J; Deo R; Mohanty CS
Indian J Dermatol; 2015; 60(5):524. PubMed ID: 26538741
[TBL] [Abstract][Full Text] [Related]
10. [Vasculitis and vasculopathy].
Marković A
Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816
[TBL] [Abstract][Full Text] [Related]
11. A case of livedoid vasculopathy in a 22-year-old man.
Leonard A; Pomeranz MK; Franks AG
J Drugs Dermatol; 2004; 3(6):678-9. PubMed ID: 15624752
[TBL] [Abstract][Full Text] [Related]
12. A Refractory Livedoid Vasculopathy Accompanied by Methylene Tetrahydrofolate Reductase Gene Polymorphism Successfully Treated with Hyperbaric Oxygen Therapy.
Lee SH; Lee Y; Choi EH
Ann Dermatol; 2023 May; 35(Suppl 1):S59-S62. PubMed ID: 37853867
[TBL] [Abstract][Full Text] [Related]
13. Medium-pressure hyperbaric oxygen therapy for livedoid vasculopathy.
Herrera-Sánchez A; Madriagal-Alvarado MJ; Moncayo G; Verdini F
Medicina (B Aires); 2022; 82(4):613-616. PubMed ID: 35904919
[TBL] [Abstract][Full Text] [Related]
14. Livedoid vasculopathy managed with hyperbaric oxygen therapy.
Bhutani S; Verma R; Verghese G
Med J Armed Forces India; 2012 Oct; 68(4):389-91. PubMed ID: 24532913
[TBL] [Abstract][Full Text] [Related]
15. Livedoid vasculopathy - A diagnostic and therapeutic challenge.
Burg MR; Mitschang C; Goerge T; Schneider SW
Front Med (Lausanne); 2022; 9():1012178. PubMed ID: 36262273
[TBL] [Abstract][Full Text] [Related]
16. [Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies].
Grasland A; Crickx B; Blanc M; Pouchot J; Vinceneux P
Ann Med Interne (Paris); 2000 Sep; 151(5):408-10. PubMed ID: 11033476
[TBL] [Abstract][Full Text] [Related]
17. Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach.
Alavi A; Hafner J; Dutz JP; Mayer D; Sibbald RG; Criado PR; Senet P; Callen JP; Phillips TJ; Romanelli M; Kirsner RS
J Am Acad Dermatol; 2013 Dec; 69(6):1033-1042.e1. PubMed ID: 24028907
[TBL] [Abstract][Full Text] [Related]
18. Treatment for Livedoid Vasculopathy: A Systematic Review.
Micieli R; Alavi A
JAMA Dermatol; 2018 Feb; 154(2):193-202. PubMed ID: 29141075
[TBL] [Abstract][Full Text] [Related]
19. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia.
Browning CE; Callen JP
Arch Dermatol; 2006 Jan; 142(1):75-8. PubMed ID: 16415390
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive review on pathogenesis, associations, clinical findings, and treatment of livedoid vasculopathy.
Seguí M; Llamas-Velasco M
Front Med (Lausanne); 2022; 9():993515. PubMed ID: 36569162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
